Methylamine

Methylamine

SCHEMBL6776180

CN.COc1cc2c(N)ncnc2cc1C#CCCCCNC(=O)OC(C)(C)C

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.45
MAP4K4 O95819 1/20 0.41
HDAC3 O15379 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2A1 P68400 1/20 0.38
BRD4 O60885 4/20 0.38
ADORA3 P0DMS8 1/20 0.36
DRD2 P14416 3/20 0.36
EGFR P00533 1/20 0.36
PDPK1 O15530 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7625181 0.85 MAP4K4 (0.40) ATMMAP4K4HDAC3HDAC4HDAC1
SCHEMBL6776188 0.83 MAP4K4 (0.39) ATMMAP4K4HDAC3HDAC4HDAC1
SCHEMBL6776169 0.83 ATM (0.42) ATMMAP4K4CSNK2A2CSNK2A1BRD4
Methylamine SCHEMBL6776480 0.82 AXL (0.41) ATMHDAC3HDAC4HDAC1HDAC7
Methylamine SCHEMBL6780338 0.81 HDAC3 (0.43) ATMHDAC3HDAC4HDAC1HDAC7
SCHEMBL6776176 0.74 SRC (0.37) MAP4K4HDAC3HDAC4HDAC1HDAC7
Methylamine SCHEMBL7141650 0.72 ADORA3 (0.42) CSNK2A2CSNK2A1BRD4ADORA3CA12
SCHEMBL4430373 0.70 ALDH1A1 (0.36) MAP4K4HDAC3HDAC4HDAC1HDAC7
SCHEMBL4420153 0.70 KDM4E (0.52) ATMMAP4K4ADORA3EGFRLYN
SCHEMBL4420146 0.70 PDE5A (0.41) MAP4K4EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6806274-B1 IMMUNOREGULATION OR IMMUNOSUPPRESSIVE AGENTS; TYROSINE KINASE INHIBITORS; PREVENTING ORGAN TRANSPLANT REJECTION; AUTOIMMUNE CONDITIONS; REDUCED SIDE EFFECTS ASTRAZENECA UK LIMITED (GB) 2004-10-19 US disclosed